Search the Blog

Creating a Lab for Lung Cancer Research

I started in May of 2014 as a Scientist in the Department of Integrative Oncology at the BC Cancer Agency Research Centre. As opposed to my previous training positions, this role is fully independent, which means it involved setting up my own laboratory with graduate students and other trainees that conduct research under my supervision.

Although it was quite a daunting process to get...

From Student to Scientist

Back when I was a student, Dr. Wan Lam had a new group that was pioneering a cutting-edge technology to enable the first comprehensive assessment of the genetic alterations that drive cancer development. Soon, I was spending my nights and weekends at the lab and after finishing my undergraduate degree, I started my PhD with Wan as my supervisor.


Dr. Will Lockwood: Developing a Passion for Cancer Research

Hi, my name is Will Lockwood and I am a scientist at the BC Cancer Agency. My path to a career in cancer research has been more straightforward than most, but was aided by the mentorship and support of many people.  

I am a B.C. boy through and through, born and raised in Kamloops. As with most kids, school—science in particular—was the last thing on my mind; hockey and lacrosse were my...

Hello from Lou Del Gobbo and Introducing September Guest Blogger

Hello everyone, I’m Lou Del Gobbo, Interim President & CEO of the BC Cancer Foundation, and I’m very pleased to introduce our September guest blogger.

Before I share what’s coming up this month on the blog, I want to extend a warm thank you to outgoing BC Cancer Foundation President & CEO Doug Nelson...

Understanding the Experiences of Oral Cancer Patients

This year, in addition to tackling yet-to-be-solved problems through research, we commenced the Patient Support Initiative (PSI). Understanding the experiences of oral cancer patients and their caregivers is key to making recommendations for a change in standard management or policy in the health care system. We expect PSI to play multiple roles:

  1. To encourage...

Translational Research: From the Laboratory to Patient Care

My primary research focus is on translational research—from bench to bedside—applying new technologies and findings from the laboratory to patient care. This involves the application of molecular and imaging tools for community screening, early detection, and management of cancerous and precancerous oral lesions.

In Canada, one in 10,000 people has oral cancer. Even with current...

Understanding Oral Cancer

In my last post, I shared how I came from Taiwan to British Columbia to study oral cancer, but my training didn’t stop after I completed my PhD.

To better understand oral cancer, I completed a three-year oral pathology residency under the direction of Dr. Robert Priddy. Through this training, I came to understand more of the clinical aspect of this disease. After I passed both...

Dr. Catherine Poh: How I Became an Oral Cancer Researcher

Hello, my name is Catherine Poh and I am an oral cancer researcher. I took the “long way” to get to where I am today.

I grew up in Taiwan and got my dental degree from the National Taiwan University in Taipei, Taiwan. Though I was getting my degree in general dentistry, I had already developed a great interest in pathology/oral pathology during my time in Taipei.  This was twenty some...

Introducing August Guest Blogger Dr. Catherine Poh

Thank you to our July guest blogger Dr. Rasika Rajapakshe for taking us behind the scenes at the BC Cancer Agency Sindi Ahluwalia Hawkins Centre for the Southern Interior, where tremendous efforts are being made to improve treatment and care for cancer patients in British Columbia.  

I’m very pleased to introduce our guest blogger for August, Dr. Catherine Poh. Dr. Poh is a clinician...

Dr. Marcel Bally: A Look at the Future of Cancer Treatment

Looking into the future for me is always about looking backwards.

When I first became interested in using drug delivery systems for cancer treatment over 30 years ago, one of the hottest research topics concerned “antibody-conjugated toxic drugs” (antibodies are proteins that can be designed to recognize cancer cells).

This research idea faltered and stumbled because our immune...


Subscribe to BC Cancer Research Centre